<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Nature</journal-id>
        <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Nature</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0028-0836</issn>
        <issn pub-type="epub">1476-4687</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC3412905</article-id>
        <article-id pub-id-type="pmcid-ver">PMC3412905.1</article-id>
        <article-id pub-id-type="pmcaid">3412905</article-id>
        <article-id pub-id-type="pmcaiid">3412905</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS374717</article-id>
        <article-id pub-id-type="pmid">22722829</article-id>
        <article-id pub-id-type="doi">10.1038/nature11213</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS374717</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA374717</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Novel mutations target distinct subgroups of medulloblastoma</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Robinson</surname>
              <given-names initials="G">Giles</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="aff" rid="A3">3</xref>
            <xref ref-type="author-notes" rid="FN1">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Parker</surname>
              <given-names initials="M">Matthew</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
            <xref ref-type="author-notes" rid="FN1">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kranenburg</surname>
              <given-names initials="TA">Tanya A.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="author-notes" rid="FN1">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lu</surname>
              <given-names initials="C">Charles</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chen</surname>
              <given-names initials="X">Xiang</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ding</surname>
              <given-names initials="L">Li</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Phoenix</surname>
              <given-names initials="TN">Timothy N.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hedlund</surname>
              <given-names initials="E">Erin</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wei</surname>
              <given-names initials="L">Lei</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
            <xref ref-type="aff" rid="A7">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zhu</surname>
              <given-names initials="X">Xiaoyan</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chalhoub</surname>
              <given-names initials="N">Nader</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Baker</surname>
              <given-names initials="SJ">Suzanne J.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Huether</surname>
              <given-names initials="R">Robert</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
            <xref ref-type="aff" rid="A8">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kriwacki</surname>
              <given-names initials="R">Richard</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A8">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Curley</surname>
              <given-names initials="N">Natasha</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Thiruvenkatam</surname>
              <given-names initials="R">Radhika</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wang</surname>
              <given-names initials="J">Jianmin</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A9">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wu</surname>
              <given-names initials="G">Gang</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rusch</surname>
              <given-names initials="M">Michael</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hong</surname>
              <given-names initials="X">Xin</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Beckford</surname>
              <given-names initials="J">Jared</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A9">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gupta</surname>
              <given-names initials="P">Pankaj</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A9">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ma</surname>
              <given-names initials="J">Jing</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A7">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Easton</surname>
              <given-names initials="J">John</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Vadodaria</surname>
              <given-names initials="B">Bhavin</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Onar-Thomas</surname>
              <given-names initials="A">Arzu</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A10">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lin</surname>
              <given-names initials="T">Tong</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A10">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Li</surname>
              <given-names initials="S">Shaoyi</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A10">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Pounds</surname>
              <given-names initials="S">Stanley</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A10">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Paugh</surname>
              <given-names initials="S">Steven</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A11">11</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zhao</surname>
              <given-names initials="D">David</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A9">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kawauchi</surname>
              <given-names initials="D">Daisuke</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A12">12</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Roussel</surname>
              <given-names initials="MF">Martine F.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A12">12</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Finkelstein</surname>
              <given-names initials="D">David</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ellison</surname>
              <given-names initials="DW">David W.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A7">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lau</surname>
              <given-names initials="CC">Ching C.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A13">13</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Bouffet</surname>
              <given-names initials="E">Eric</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A14">14</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hassall</surname>
              <given-names initials="T">Tim</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A15">15</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gururangan</surname>
              <given-names initials="S">Sridharan</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A16">16</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Cohn</surname>
              <given-names initials="R">Richard</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A17">17</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Fulton</surname>
              <given-names initials="RS">Robert S.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Fulton</surname>
              <given-names initials="LL">Lucinda L.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dooling</surname>
              <given-names initials="DJ">David J.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ochoa</surname>
              <given-names initials="K">Kerri</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gajjar</surname>
              <given-names initials="A">Amar</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mardis</surname>
              <given-names initials="ER">Elaine R.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
            <xref ref-type="aff" rid="A18">18</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wilson</surname>
              <given-names initials="RK">Richard K.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A6">6</xref>
            <xref ref-type="aff" rid="A19">19</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Downing</surname>
              <given-names initials="JR">James R.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A7">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names initials="J">Jinghui</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gilbertson</surname>
              <given-names initials="RJ">Richard J.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>St Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
</aff>
        <aff id="A2"><label>2</label>Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A3"><label>3</label>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A4"><label>4</label>Department of Computational Biology and Bioinformatics, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A5"><label>5</label>The Genome Institute, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63108, USA.
</aff>
        <aff id="A6"><label>6</label>Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63108, USA.
</aff>
        <aff id="A7"><label>7</label>Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A8"><label>8</label>Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A9"><label>9</label>Department of Information Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A10"><label>10</label>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A11"><label>11</label>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A12"><label>12</label>Department of Tumour Biology and Genetics, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
</aff>
        <aff id="A13"><label>13</label>Texas Children’s Cancer and Hematology Centers, 6701 Fannin St., Ste. 1420, Houston, TX 77030.
</aff>
        <aff id="A14"><label>14</label>The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G 1X8.
</aff>
        <aff id="A15"><label>15</label>The Royal Children’s Hospital, 50 Flemington Road, Parkville Victoria 3052 Australia.
</aff>
        <aff id="A16"><label>16</label>Duke University Medical Center, 102382, Durham, NC 27710
</aff>
        <aff id="A17"><label>17</label>The School of Women’s and Children’s Health, University of New South Wales, Kensington, NSW, Australia.
</aff>
        <aff id="A18"><label>18</label>Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63108, USA.
</aff>
        <aff id="A19"><label>19</label>Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63108, USA.
</aff>
        <author-notes>
          <corresp id="CR1">Correspondence should be addressed to: RJG (<email>Richard.Gilbertson@stjude.org</email>); JZ (<email>Jinghui.Zhang@stjude.org</email>); JRD (<email>James.Downing@stjude.org</email>); RKW (<email>rwilson@wustl.edu</email>).</corresp>
          <fn fn-type="equal" id="FN1">
            <label>*</label>
            <p id="P1">These authors contributed equally to the work.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>2</day>
          <month>8</month>
          <year>2012</year>
        </pub-date>
        <volume>488</volume>
        <issue>7409</issue>
        <issue-id pub-id-type="pmc-issue-id">212801</issue-id>
        <fpage>43</fpage>
        <lpage>48</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>23</day>
              <month>07</month>
              <year>2012</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>02</day>
              <month>02</month>
              <year>2013</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>02</day>
              <month>02</month>
              <year>2013</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-05 22:06:41.443">
              <day>05</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <permissions>
          <license>
            <license-p>Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
          </license>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-374717.pdf"/>
        <abstract>
          <title>Summary</title>
          <p id="P2">Medulloblastoma is a malignant childhood brain tumour comprising four discrete subgroups. To identify mutations that drive medulloblastoma we sequenced the entire genomes of 37 tumours and matched normal blood. One hundred and thirty-six genes harbouring somatic mutations in this discovery set were sequenced in an additional 56 medulloblastomas. Recurrent mutations were detected in 41 genes not yet implicated in medulloblastoma: several target distinct components of the epigenetic machinery in different disease subgroups, e.g., regulators of H3K27 and H3K4 trimethylation in subgroup-3 and 4 (e.g., <italic toggle="yes">KDM6A</italic> and <italic toggle="yes">ZMYM3</italic>), and CTNNB1-associated chromatin remodellers in WNT-subgroup tumours (e.g., <italic toggle="yes">SMARCA4</italic> and <italic toggle="yes">CREBBP</italic>). Modelling of mutations in mouse lower rhombic lip progenitors that generate WNT-subgroup tumours, identified genes that maintain this cell lineage (<italic toggle="yes">DDX3X</italic>) as well as mutated genes that initiate (<italic toggle="yes">CDH1</italic>) or cooperate (<italic toggle="yes">PIK3CA</italic>) in tumourigenesis. These data provide important new insights into the pathogenesis of medulloblastoma subgroups and highlight targets for therapeutic development.</p>
        </abstract>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
    <body>
      <p id="P3">Medulloblastoma is the most common malignant childhood brain tumor<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. The disease includes four subgroups (Sonic Hedgehog (SHH)-subgroup, WNT-subgroup, subgroup-3 and subgroup-4) defined primarily by gene expression profiling that display differences in karyotype, histology and prognosis<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. Studies of genetically engineered mice show these tumours arise from different cell types: SHH-subgroup medulloblastomas develop from committed cerebellar granule neuron progenitors (GNPs) in <italic toggle="yes">Ptch1<sup>+/−</sup></italic> mice<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>; WNT-subgroup tumours are generated by lower rhombic lip progenitors (LRLPs) in <italic toggle="yes">Blbp-Cre</italic> ; <italic toggle="yes">Ctnnb1<sup>+/lox(Ex3)</sup></italic> ; <italic toggle="yes">Tp53<sup>flx/flx</sup></italic> mice<sup><xref rid="R5" ref-type="bibr">5</xref></sup>; while subgroup-3 medulloblastomas likely arise from an undefined class of cerebellar progenitors<sup><xref rid="R6" ref-type="bibr">6</xref></sup>. The identification of medulloblastoma subgroups has not changed clinical practice. All patients currently receive the same combination of surgery, radiation and chemotherapy. This aggressive treatment fails to cure two thirds of patients with subgroup-3 disease, and probably over-treats children with WNT-subgroup medulloblastoma who invariably survive with long term cognitive and endocrine side effects<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup>. Drugs targeting the genetic alterations that drive each medulloblastoma subgroup could prove more effective and less toxic, but the identity of these alterations remains largely unknown.</p>
      <sec id="S1">
        <title>The genomic landscape of medulloblastoma</title>
        <p id="P4">To identify genetic alterations that drive medulloblastoma, we performed whole genome sequencing (WGS) of DNA from 37 tumours and matched normal blood (discovery cohort). Tumours were subgrouped by gene expression (WNT-subgroup, n=5; SHH-subgroup, n=5; subgroup-3, n=6; subgroup-4, n=19; ‘unclassified’ [profiles not available], n=2. <xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 1</xref>-<xref ref-type="supplementary-material" rid="SD1">3</xref> and <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>). Validation of all putative somatic alterations including single nucleotide variations (SNVs), insertion/deletions (indels) and structural variations (SVs) identified by CREST<sup><xref rid="R8" ref-type="bibr">8</xref></sup>, was conducted for 12 tumours using custom capture arrays and Illumina-based DNA sequencing (<xref ref-type="supplementary-material" rid="SD10">Supplementary Table 2</xref>). Putative coding alterations and SVs were validated in the remaining 25 ‘discovery cohort’ cases by polymerase chain reaction and Sanger-based sequencing. Mutation frequency was determined in a separate ‘validation cohort’ of 56 medulloblastomas (WNT-subgroup, n=6; SHH-subgroup, n=8; subgroup-3, n=11; subgroup-4, n=19; unclassified, n=12; <xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD3">Supplementary Table 1</xref>).</p>
        <p id="P5">WGS of the ‘discovery cohort’ detected 22,887 validated or high-quality somatic sequence mutations (SNVs and indels), 536 validated or curated SVs, and 5,802 copy number variations (CNVs, 92% concordant with 6.0 SNP mapping arrays; <xref ref-type="supplementary-material" rid="SD11">Supplementary Tables 3</xref>-<xref ref-type="supplementary-material" rid="SD14">6</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 4</xref>-<xref ref-type="supplementary-material" rid="SD1">7</xref>). In all but five tumours with the highest mutation rates, &gt;50% of SNVs were C&gt;T/G&gt;A transitions (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>). The mean missense:silent mutation ratio was 3.6:1 and 40% of all missense mutations were predicted to be deleterious, suggesting a selective pressure for SNVs that impact protein coding (<xref ref-type="supplementary-material" rid="SD13">Supplementary Table 5</xref>). Global patterns of total SNVs and amplifications varied significantly among medulloblastoma subgroups, even when corrected for age and sex, supporting the notion that these tumours are distinct pathological entities (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 6</xref>). Custom capture-based analysis of the allele frequency of all somatic mutations in 12 medulloblastomas allowed us to predict the ancestry of certain genetic alterations, suggesting that aneuploidy precedes widespread sequence mutation in medulloblastomas with highly mutated genomes (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 9</xref>-<xref ref-type="supplementary-material" rid="SD1">11</xref>).</p>
      </sec>
      <sec id="S2">
        <title>Novel copy number variations, structural alterations and heritable mutations are rare in medulloblastoma</title>
        <p id="P6">The repertoire of focally amplified or deleted genes appears to be very limited in medulloblastoma. We detected expected<sup><xref rid="R2" ref-type="bibr">2</xref></sup> gains of <italic toggle="yes">MYC</italic>, <italic toggle="yes">MYCN</italic> and <italic toggle="yes">OTX2</italic> in subgroup-3 and 4, but no novel recurrent amplifications (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 12</xref>, <xref ref-type="supplementary-material" rid="SD15">Supplementary Table 7</xref>). In keeping with recent reports<sup><xref rid="R9" ref-type="bibr">9</xref></sup>, high-level amplification of <italic toggle="yes">MYCN</italic> in subgroup-3 sample #16 (sample numbering as <xref ref-type="fig" rid="F1">Figure 1</xref>) was generated by chromothripsis; although chromothripsis was observed infrequently (n=2/37 of ‘discovery cohort’; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 13</xref>).</p>
        <p id="P7">Focal homo- or heterozygous deletion of genes previously implicated in medulloblastoma were also detected (e.g., <italic toggle="yes">PTCH1, PTEN,</italic>
<xref ref-type="fig" rid="F1">Figure 1</xref>)<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup> but novel recurrent focal deletions were rare. Three subgroup-4 tumours (#11-13) and one unclassified tumour, deleted <italic toggle="yes">DDX31, AK8</italic> and <italic toggle="yes">TSC1</italic> at 9q34.14 in concert with <italic toggle="yes">OTX2</italic> amplification, suggesting these alterations are cooperative (P&lt;0.0005, Fisher’s exact). The breakpoint in this deletion occurs in <italic toggle="yes">DDX31</italic> and two samples contained a missense mutation (subgroup-4 #15) and complex rearrangement (unidentified case SJMB026) in this gene, suggesting <italic toggle="yes">DDX31</italic> is the target of these alterations (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 14</xref>).</p>
        <p id="P8">Over 50% of SVs detected by WGS broke the coding region of at least one gene, but less than 2% (n=6/314, excluding two tumours with excessive SVs) encode potential in-frame fusion proteins (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 15</xref>); none affect the same gene or signal pathway. Therefore, fusion proteins are likely to be an uncommon transforming mechanism in medulloblastoma.</p>
        <p id="P9">Although germline mutations in <italic toggle="yes">TP53, PTCH1, APC,</italic> and <italic toggle="yes">CREBBP</italic>, predispose to medulloblastoma<sup><xref rid="R11" ref-type="bibr">11</xref>-<xref rid="R14" ref-type="bibr">14</xref></sup>, only 23 mutations previously associated with cancer were detected in ‘discovery cohort’ germlines: only one of these - in a known case of Turcot’s syndrome - was accompanied with a somatic mutation (germline APC Y935*/somatic deletion: WNT-subgroup #11, <xref ref-type="supplementary-material" rid="SD16">Supplementary Table 8</xref>). Thus, inherited forms of medulloblastoma appear to be rare in our cohort.</p>
      </sec>
      <sec id="S3">
        <title>Novel recurrent sequence mutations target distinct medulloblastoma subgroups</title>
        <p id="P10">Since SVs and CNVs are unlikely to drive most medulloblastomas, we looked to see if recurrent (&gt;2 samples), somatic SNVs and/or indels might target discrete genes and pathways. This analysis identified 49 genes, across all 93 tumors, that were targeted by non-silent, recurrent, somatic mutations: 84% (n=41/49) are not yet implicated in medulloblastoma (<xref ref-type="supplementary-material" rid="SD17">Supplementary Tables 9</xref> and <xref ref-type="supplementary-material" rid="SD4">10</xref>). Several of these congregated in disease subgroups and converged on specific cell pathways (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref> and <xref ref-type="supplementary-material" rid="SD5">Table 11</xref>).</p>
        <sec id="S4">
          <title>Writing, reading and erasing of histone methylation is deregulated in subgroup-3 and 4 medulloblastomas</title>
          <p id="P11">The H3K27 trimethyl mark (H3K27me3) represses lineage specific genes in stem cells (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>)<sup><xref rid="R15" ref-type="bibr">15</xref></sup>. H3K27me3 is written by the polycomb repressive complex 2 (PRC2) that includes the methylase EZH2<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref></sup>, and erased during differentiation by the demethylase KDM6A<sup><xref rid="R18" ref-type="bibr">18</xref></sup>. As H3K27me3 is erased, chromatin remodelers recruited to H3K4me3 promote differentiation e.g., CHD7<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup>. This process is tightly controlled during development and deregulated in cancers: <italic toggle="yes">EZH2</italic> is mutated in lymphomas<sup><xref rid="R21" ref-type="bibr">21</xref></sup>, and upregulated in breast<sup><xref rid="R22" ref-type="bibr">22</xref></sup> and prostate<sup><xref rid="R23" ref-type="bibr">23</xref></sup> cancer; while biallelic inactivation of <italic toggle="yes">KDM6A</italic> (Xp11.2) or <italic toggle="yes">KDM6A</italic> and its paralog <italic toggle="yes">UTY</italic> (Yq11), occurs in adult female and male cancers, respectively<sup><xref rid="R24" ref-type="bibr">24</xref></sup>.</p>
          <p id="P12">Hypergeometric distribution analyses revealed selective mutation of histone modifiers in subgroup-3 and 4 medulloblastomas (<xref ref-type="supplementary-material" rid="SD5">Supplementary Table 11</xref>). Six subgroup-4, one subgroup-3, and one unclassified medulloblastoma contained novel inactivating mutations in <italic toggle="yes">KDM6A</italic> (<xref ref-type="fig" rid="F1">Figures 1</xref> and <xref ref-type="fig" rid="F2">2</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 8</xref> and <xref ref-type="supplementary-material" rid="SD1">16</xref>). The single female with a <italic toggle="yes">KDM6A</italic> splice site mutation deleted the second allele that escapes X inactivation<sup><xref rid="R25" ref-type="bibr">25</xref></sup> (subgroup-4 #15), and 57% (n=4/7) of <italic toggle="yes">KDM6A</italic>-mutant male medulloblastomas deleted chromosome Y, compared with only 6% (n=3/51) of male, <italic toggle="yes">KDM6A</italic> wild-type tumours (P&lt;0.005, Fisher’s exact; <xref ref-type="fig" rid="F1">Figure 1</xref>). Thus, a two-hit model of <italic toggle="yes">KDM6A–UTY</italic> tumour suppression appears to operate in subgroup-4 medulloblastomas. Notably, mutations in six other KDM family members (<italic toggle="yes">KDM1A, KDM3A</italic>, <italic toggle="yes">KDM4C</italic>, <italic toggle="yes">KDM5A</italic>, <italic toggle="yes">KDM5B</italic> and <italic toggle="yes">KDM7A</italic>) were detected exclusively in subgroup-3 and 4 tumours, implicating broad disruption of lysine demethylation in these medulloblastomas (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD5">Supplementary Table 11</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 16</xref>).</p>
          <p id="P13">Subgroup-3 and 4 medulloblastomas also gained and overexpressed <italic toggle="yes">EZH2</italic> (7q35-34) that writes H3K27me3, and contained novel inactivating mutations in effectors and regulators of the H3K4me3 mark<sup><xref rid="R26" ref-type="bibr">26</xref></sup> (<xref ref-type="fig" rid="F2">Figure 2a</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>). Gain of 7q was significantly enriched among subgroup-3 and 4 medulloblastomas (P&lt;0.005 Fisher’s exact) and correlated directly with EZH2 expression. Indeed, <italic toggle="yes">EZH2</italic> was the 8<sup>th</sup> most significantly overexpressed gene on chromosome 7 among subgroup-3 and 4 medulloblastomas that gained chromosome 7q relative to those with diploid chromosome 7 (P&lt;0.005, Bonferroni correction). Nonsense and frameshift mutations were detected in <italic toggle="yes">CHD7</italic> in four subgroup-3 and 4 tumours. <italic toggle="yes">ZMYM3</italic> (Xq13.1) that participates in a protein complex with KDM1A to regulate gene expression at the H3K4me3 mark<sup><xref rid="R27" ref-type="bibr">27</xref></sup> was targeted by novel frameshift, nonsense and missense mutations in three male subgroup-4 medulloblastomas. All three tumours with mutations in <italic toggle="yes">ZMYM3</italic> also mutated <italic toggle="yes">KDM6A</italic> (subgroup-4 #19, 20) or <italic toggle="yes">KDM1A</italic> (subgroup-4 #21) suggesting these alterations are cooperative. Remarkably, <italic toggle="yes">KDM6A, CHD7</italic> and <italic toggle="yes">ZMYM3</italic> mutations were confined to subgroup-3 and 4, and clustered in samples with sub-median EZH2 expression levels (<xref ref-type="fig" rid="F2">Figure 2a</xref>; P&lt;0.05, Fisher’s exact). These data suggest that subgroup-3 and 4 medulloblastomas retain a stem-like epigenetic state by aberrantly writing (EZH2 upregulation) or preserving (<italic toggle="yes">KDM6A-UTY</italic> inactivation) H3K27me3, or disrupting H3K4me3 associated transcription (<italic toggle="yes">CHD7</italic> and <italic toggle="yes">ZMYM3</italic> inactivation). Indeed, human and mouse subgroup-3 and 4 medulloblastomas contained significantly more H3K27me3 than did WNT or SHH-subgroup tumours (<xref ref-type="fig" rid="F2">Figure 2b</xref>). Thus, gain of <italic toggle="yes">EZH2</italic> and loss of <italic toggle="yes">KDM6A</italic> likely maintains H3K27me3 in subgroup-3 and 4 medulloblastomas.</p>
          <p id="P14">Finally, we looked to see if the differential expression of H3K27me3 among medulloblastoma subgroups reflects ancestral chromatin marking in the progenitors that generate these tumours (<xref ref-type="fig" rid="F2">Figure 2b</xref>). Relatively low levels of H3K27me3 were detected in LRLPs and committed GNPs that generate WNT and SHH-subgroup medulloblastomas respectively<sup><xref rid="R3" ref-type="bibr">3</xref>-<xref rid="R5" ref-type="bibr">5</xref></sup>, potentially explaining why mutations that preserve this epigenetic mark are absent from these tumours. We recently showed that subgroup-3 medulloblastomas arise from a rare fraction of cerebellar progenitors<sup><xref rid="R6" ref-type="bibr">6</xref></sup>. We are currently investigating if these progenitors are found among the H3K27me<sup><xref rid="R3" ref-type="bibr">3</xref></sup> positive cells seen in the external germinal layer (<xref ref-type="fig" rid="F2">Figure 2b</xref>).</p>
        </sec>
        <sec id="S5">
          <title>Novel mutations in WNT-subgroup medulloblastomas target CTNNB1-associated chromatin remodelers and regulators of LRLPs</title>
          <p id="P15">WNT-subgroup medulloblastomas contained mutations in epigenetic regulators that are different to those seen in subgroup-3 and 4 disease. CTNNB1, the principal effector of the WNT pathway, forms a transcription factor with the T cell factor/lymphoid enhancer factor (TCF/LEF)<sup><xref rid="R28" ref-type="bibr">28</xref></sup>. The c-terminus of CTNNB1 then recruits a series of protein complexes that remodel chromatin and promote transcription at WNT-responsive genes (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>). These include: histone acetyltransferases (e.g., CREBBP and TRRAP-TIP60 complexes)<sup><xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup>; ATPases of the SWI/SNF family (e.g., SMARCA4)<sup><xref rid="R30" ref-type="bibr">30</xref></sup>; and the Mediator complex that coordinates RNA polymerase II placement (e.g., MED13)<sup><xref rid="R31" ref-type="bibr">31</xref></sup>. As expected, &gt;70% (n=8/11) of WNT-medulloblastomas contained mutations that stabilise CTNNB1 (<xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>; P&lt;0.0001, Fishers exact)<sup><xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup>. A single subgroup-3 case (#5) also mutated <italic toggle="yes">CTNNB1,</italic> but this mutation has not been reported in cancer, did not upregulate nuclear CTNNB1 (<xref ref-type="fig" rid="F1">Figure 1</xref>) and is of unclear significance. Remarkably, six WNT-subgroup medulloblastomas mutated chromatin modifiers that are recruited to TCF/LEF WNT-responsive genes by CTNNB1 (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>): four WNT-subgroup tumours contained heterozygous missense mutations in the helicase domain of <italic toggle="yes">SMARCA4</italic> (P&lt;0.002, Fisher’s exact); two samples, including one with a <italic toggle="yes">SMARCA4</italic> mutation (#5), contained nonsense mutations in <italic toggle="yes">CREBBP</italic> (WNT-subgroup enrichment P&lt;0.02, Fisher’s exact); and missense mutations in <italic toggle="yes">TRRAP</italic> and <italic toggle="yes">MED13</italic> were detected in a single WNT-subgroup medulloblastoma each. Thus, in addition to stabilization of CTNNB1, the development of WNT-subgroup medulloblastoma may require disruption of chromatin remodeling at WNT-responsive genes.</p>
          <p id="P16">A small number of WNT-subgroup medulloblastomas lack mutations in <italic toggle="yes">CTNNB1</italic> or <italic toggle="yes">APC,</italic> suggesting alternative mechanisms drive aberrant WNT-signals in these tumours. Three WNT-subgroup medulloblastomas in our series contained wild-type <italic toggle="yes">CTNNB1</italic> (#1, 10 and 11, <xref ref-type="fig" rid="F1">Figure 1</xref>). Sample #11 inactivated <italic toggle="yes">APC</italic> as the sole case of Turcot’s Syndrome in our study, but this tumour and sample #10 also contained novel missense mutations in <italic toggle="yes">CDH1</italic> (R63G, V329F; <xref ref-type="fig" rid="F1">Figure 1</xref> WNT-subgroup enrichment P&lt;0.05, Fisher’s exact). CDH1 sequesters CTNNB1 at the cell membrane<sup><xref rid="R34" ref-type="bibr">34</xref></sup>, and mutations that disrupt this interaction promote WNT signaling in adult cancers<sup><xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref></sup>. The functional consequences of CDH1<sup>R63G</sup> and CDH1<sup>V329F</sup> remain to be determined, but their restriction to WNT-subgroup tumours; mutual exclusivity with <italic toggle="yes">CTNNB1</italic> mutations; and adjacency to residues mutated in breast cancer (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sanger.ac.uk/genetics/CGP/cosmic/">http://www.sanger.ac.uk/genetics/CGP/cosmic/</ext-link>), suggest these might promote aberrant WNT signals in medulloblastoma.</p>
          <p id="P17">We showed previously that mutant Ctnnb1 initiates WNT-subgroup medulloblastoma by arresting the migration of LRLPs from the embryonic dorsal brainstem to the pontine grey nucleus (PGN)<sup><xref rid="R5" ref-type="bibr">5</xref></sup>. Therefore, to test if disruption of CDH1 might substitute for mutant CTNNB1 in medulloblastoma, we used shRNAs to knock down Cdh1 in embryonic day (E) 14.5 mouse LRLPs (<xref ref-type="fig" rid="F3">Figure 3a to c</xref>). Deletion of Cdh1 expression upregulated Tcf/Lef mediated gene transcription in LRLPs and more than doubled their self-renewal capacity (<xref ref-type="fig" rid="F3">Figure 3b</xref>). Furthermore, <italic toggle="yes">in utero</italic> electroporation of LRLPs with Cdh1 shRNAs impeded their migration from the dorsal brainstem to the PGN with an efficiency similar to that of mutant Ctnnb1 (<xref ref-type="fig" rid="F3">Figure 3d,e</xref>; see <xref ref-type="supplementary-material" rid="SD2">Supplementary Methods</xref>). These data support the hypothesis that <italic toggle="yes">CDH1</italic> suppresses the formation of WNT-subgroup medulloblastoma by regulating WNT-signals in LRLPs.</p>
          <p id="P18">WNT-subgroup medulloblastomas were also enriched for novel, recurrent somatic missense mutations in the DEAD-Box RNA helicase <italic toggle="yes">DDX3X</italic> at Xp11.3 (P&lt;0.0001, Fisher’s exact; <xref ref-type="fig" rid="F1">Figure 1</xref>). DDX3X regulates several critical cell processes including chromosome segregation<sup><xref rid="R37" ref-type="bibr">37</xref></sup>, cell cycle progression<sup><xref rid="R38" ref-type="bibr">38</xref></sup>, gene transcription and translation<sup><xref rid="R39" ref-type="bibr">39</xref></sup>. Previously reported cancer associated mutations in <italic toggle="yes">DDX3X</italic> disrupt the ATPase activity of the protein, but seven of eight mutations identified in our series clustered in the DEAD-box domain (<xref ref-type="supplementary-material" rid="SD1">Supplementary Information</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 8</xref>). Structural modeling predicts that these mutations interfere with nucleic acid binding, possibly altering specificity and/or affinity for RNA substrates, rather than inactivating DDX3X (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figures 17</xref>-<xref ref-type="supplementary-material" rid="SD1">22</xref>). Indeed, the wild-type allele of <italic toggle="yes">DDX3X</italic> that escapes X inactivation<sup><xref rid="R25" ref-type="bibr">25</xref></sup> was retained by two of three <italic toggle="yes">DDX3X</italic>-mutant female medulloblastomas, and knock-down of <italic toggle="yes">Ddx3x</italic> halved the self-renewal rate of mouse LRLPs, suggesting this protein is important for the proliferation and/or maintenance of the LRLP lineage (<xref ref-type="fig" rid="F3">Figure 3b</xref>).</p>
          <p id="P19">To better understand the role of DDX3X in WNT-subgroup medulloblastoma, we employed our <italic toggle="yes">in utero</italic> migration assay to assess the impact of <italic toggle="yes">Ddx3x</italic> shRNAs, mutant-<italic toggle="yes">Ddx3x</italic><sup>T275M</sup> (identified in WNT-sample #9) or mutant-<italic toggle="yes">Ddx3x</italic><sup>G325E</sup> (WNT-sample #8) on LRLPs. Remarkably, while <italic toggle="yes">Ddx3x</italic> shRNAs were expressed abundantly in E14.5 brainstem cells within 48 hours of electroporation, &lt;0.5% of <italic toggle="yes">Ddx3x-</italic> shRNA-positive cells were present by postnatal day 1, confirming the critical importance of this gene to maintain the LRLP lineage (<xref ref-type="fig" rid="F3">Figure 3d,e</xref>). In stark contrast, mice electroporated with either mutant-<italic toggle="yes">Ddx3x</italic><sup>T275M</sup> or <italic toggle="yes">Ddx3x</italic><sup>G325E</sup> consistently contained ~50% more labeled cells at postnatal day (P) 1 than did controls, although these cells migrated normally (<xref ref-type="fig" rid="F3">Figure 3d,e</xref> and data not shown). Thus, mutations in <italic toggle="yes">DDX3X</italic> may contribute to WNT-subgroup medulloblastoma by increasing LRLP proliferation rather than perturbing the migration of their daughters. Notably, comparable knock-down <italic toggle="yes">in utero</italic> of <italic toggle="yes">Mll2, Gabrg1</italic>, and <italic toggle="yes">Kdm6a</italic> that were selectively mutated in non-WNT medulloblastomas had no apparent impact on LRLPs; supporting the value of our assay for assessing WNT-subgroup specific mutations and underscoring the importance of cell context for functional studies of genes mutated in cancer subgroups.</p>
        </sec>
        <sec id="S6">
          <title>PIK3CA mutations promote but don’t initiate WNT-subgroup medulloblastoma</title>
          <p id="P20">Cancer-associated, activating mutations in <italic toggle="yes">PIK3CA</italic> were detected in a single case each of WNT (PIK3CA<sup>Q546K</sup>), SHH (PIK3CA<sup>H1047R</sup>) and subgroup-4 (PIK3CA<sup>N345K</sup>) medulloblastoma (<xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 23</xref>). Although <italic toggle="yes">PIK3CA</italic> mutations are common in adult cancers<sup><xref rid="R40" ref-type="bibr">40</xref></sup> and reported in medulloblastoma<sup><xref rid="R41" ref-type="bibr">41</xref></sup>, their role in tumourigenesis remains controversial. In particular it is not known if these mutations initiate or progress cancer. To test this, we generated mice that express a conditional allele of the <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> mutation. Mice harboring <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> or <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> and <italic toggle="yes">Tp53<sup>flx/flx</sup></italic> were bred with <italic toggle="yes">Blbp-Cre</italic> that drives efficient recombination in LRLPs<sup><xref rid="R5" ref-type="bibr">5</xref></sup>. <italic toggle="yes">Blbp-Cre</italic> ; <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> mice, with or without <italic toggle="yes">Tp53<sup>flx/flx</sup></italic>, survived tumour free for a median of 212 days with no evidence of aberrant LRLP migration (<xref ref-type="fig" rid="F4">Figure 4a</xref> and data not shown). In stark contrast, 100% (n=11/11) of <italic toggle="yes">Blbp-Cre</italic> ; <italic toggle="yes">Ctnnb1<sup>+/lox(Ex3)</sup></italic> ; <italic toggle="yes">Tp53<sup>+/flx</sup></italic> ; <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> mice developed WNT-subgroup medulloblastomas by 3 months of age: only 4% (n=2/54) of <italic toggle="yes">Blbp-Cre</italic> ; <italic toggle="yes">Ctnnb1<sup>+/lox(Ex3)</sup></italic> ; <italic toggle="yes">Tp53<sup>+/flx</sup></italic> mice develop WNT-medulloblastoma by 11 months (<xref ref-type="fig" rid="F4">Figure 4a,b</xref>). <italic toggle="yes">Pik3ca</italic> wild-type and mutant mouse medulloblastomas displayed similar ‘classic’ histologies and nuclear Ctnnb1<sup>+</sup>, but <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> mutant tumors contained greater AKT pathway activity as measured by pS6 and p4EBP1 immunostaining. Thus mutations in <italic toggle="yes">PIK3CA</italic> likely activate the AKT pathway to progress, rather than initiate, WNT-medulloblastoma.</p>
        </sec>
        <sec id="S7">
          <title>SHH-subgroup medulloblastomas</title>
          <p id="P21">Four of 13 SHH-subgroup medulloblastomas contained expected biallelic inactivating alterations in <italic toggle="yes">SUFU</italic> or <italic toggle="yes">PTCH1.</italic> What drives aberrant SHH-signals in the remaining cases remains unclear. These tumours contained mutations in <italic toggle="yes">MLL2, TP53,</italic> and <italic toggle="yes">PTEN</italic> that have been reported previously in medulloblastoma<sup><xref rid="R42" ref-type="bibr">42</xref></sup>; but these mutations occur in other subgroups and are not known to activate SHH signals. Two SHH-subgroup tumours (#11 and 12) contained identical novel T48M mutations in gamma-aminobutyric acid (GABA) A receptor, gamma 1 that is predicted to be deleterious (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="supplementary-material" rid="SD17">Supplementary Table 9</xref>). Disruption of GABA<sub>A</sub> receptors can enhance neural stem cell proliferation<sup><xref rid="R43" ref-type="bibr">43</xref></sup>, suggesting these mutations might deregulate the proliferation of GNPs that generate SHH-subgroup medulloblastomas.</p>
        </sec>
      </sec>
      <sec sec-type="discussion" id="S8">
        <title>Discussion</title>
        <p id="P22">We have identified several, new, recurrent, somatic mutations in specific subgroups of medulloblastoma. Alterations affecting <italic toggle="yes">EZH2</italic>, <italic toggle="yes">KDM6A, CHD7</italic> and <italic toggle="yes">ZMYM3</italic> appear to disrupt chromatin marking of genes in subgroup-3 and 4 tumours. Further epigenetic studies will be required to uncover the identity of these genes, but evidence suggests these may include <italic toggle="yes">OTX2, MYC</italic> and <italic toggle="yes">MYCN<sup><xref rid="R44" ref-type="bibr">44</xref>,<xref rid="R45" ref-type="bibr">45</xref></sup></italic>. Since amplification of these genes was detected almost exclusively in subgroup-3 and 4 tumours that lacked mutations in <italic toggle="yes">KDM6A, CHD7</italic> or <italic toggle="yes">ZMYM3,</italic> it is tempting to speculate that these genetic alterations target common transforming pathways. A recent study detected recurrent mutations in three other chromatin remodelers in medulloblastoma<sup><xref rid="R42" ref-type="bibr">42</xref></sup>: <italic toggle="yes">SMARCA4, MLL2</italic> and <italic toggle="yes">MLL3,</italic> but this study did not include details of tumour subgroup. Here, we show that mutations in <italic toggle="yes">SMARCA4</italic>, <italic toggle="yes">CREBBP</italic>, <italic toggle="yes">TRRAP</italic> and <italic toggle="yes">MED13</italic> are enriched in WNT-subgroup medulloblastomas; thereby uncovering potential cooperative mutations in chromatin remodelers and their binding-partner oncogene, CTNNB1. Thus, disruptions in the epigenetic machinery of medulloblastoma are likely to be subgroup specific and may cooperate with other oncogenic mutations. The low incidence of <italic toggle="yes">MLL2</italic> mutations detected in our study relative to Parsons et al.,<sup><xref rid="R42" ref-type="bibr">42</xref></sup> likely reflects differences the our study populations (see <xref ref-type="supplementary-material" rid="SD1">Supplementary Results</xref>).</p>
        <p id="P23">Although medulloblastoma is more prevalent in males, especially subgroup-3 and 4 disease<sup><xref rid="R46" ref-type="bibr">46</xref></sup>, the reason for this sex bias is unknown. One potential explanation is the location of medulloblastoma oncogenes or tumour suppressor genes on chromosome X<sup><xref rid="R47" ref-type="bibr">47</xref></sup>. Three of the most recurrently mutated genes detected in our study are located on chromosome X, of which two (<italic toggle="yes">ZMYM3</italic> and <italic toggle="yes">KDM6A</italic>) were observed almost exclusively in males. Mutation of these genes might explain some of the male sex-bias in medulloblastoma. The third mutated X chromosome gene, <italic toggle="yes">DDX3X,</italic> is more likely to be a WNT-medulloblastoma oncogene. Three of four female medulloblastomas carried heterozygous mutations in <italic toggle="yes">DDX3X</italic> that escapes X inactivation<sup><xref rid="R25" ref-type="bibr">25</xref></sup> and our functional data indicate that mutations in this gene provide a proliferative advantage to LRLPs that generate these tumours.</p>
        <p id="P24">Our findings also have important implications for drug development. Inhibitors of the epigenetic machinery, especially those that maintain H3K27me3 e.g., EZH2 methylases, may be useful treatments of subgroup-3 and 4 disease. These tumours include the most aggressive forms of medulloblastoma for which treatment options are limited. Mutations that activate PIK3CA and DDX3X in WNT-subgroup tumors might also be targeted with novel therapeutic strategies<sup><xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref></sup>. Future clinical trials of drugs that target these mutant proteins must recruit the appropriate patient populations, since we show mutations display subgroup-specificity in medulloblastoma. Our accurate mouse models of WNT, SHH and subgroup-3 medulloblastoma should help considerably with future studies of the biological and therapeutic significance of the novel genetic alterations described in this study.</p>
      </sec>
      <sec sec-type="methods" id="S9">
        <title>Methods summary</title>
        <p id="P25">Human tumour and matched blood samples were obtained with informed consent through an institutional review board approved protocol at St Jude Children’s Research Hospital. Whole genome sequencing (WGS) and analysis of WGS data were performed as previously described<sup><xref rid="R50" ref-type="bibr">50</xref></sup>. Details of sequence coverage, custom capture and other validation procedures are provided in <xref ref-type="supplementary-material" rid="SD1">Supplementary Information</xref> (<xref ref-type="supplementary-material" rid="SD6">Supplementary Tables 12</xref>-<xref ref-type="supplementary-material" rid="SD9">15</xref>). Sequence and SNP array data were deposited in dbGaP (dbGaP accession number: phs000409, SRA accession number: SRP008292). Immunohistochemistry and immunofluorescence of human and mouse tissues were performed using routine techniques and primary antibodies of the appropriate tissues as described (<xref ref-type="supplementary-material" rid="SD2">Supplementary Methods</xref>). Medulloblastoma mRNA and DNA profiles were generated using Affymetrix U133v2 and SNP 6.0 arrays, respectively (<xref ref-type="supplementary-material" rid="SD2">Supplementary Methods</xref>). Reverse transcriptase Real Time-PCR analysis of genes targeted in mouse LRLPs by shRNAs were performed as described previously<sup><xref rid="R32" ref-type="bibr">32</xref></sup>. LRLPs were isolated and transduced with indicated lentiviruses in stem cell cultures or targeted <italic toggle="yes">in utero</italic> with shRNAs or mutant cDNA sequences by electroporation as described (<xref ref-type="supplementary-material" rid="SD1">Supplementary Information</xref>)<sup><xref rid="R5" ref-type="bibr">5</xref></sup>. Mice harbouring a cre-inducible <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> allele were generated using homologous recombination: A lox-puro-STOP-lox cassette was introduced immediately upstream of the exon containing the initiation codon, exon 9 was replaced with an exon containing the E545K mutation. <italic toggle="yes">Pik3ca<sup>E545K</sup></italic> mice were bred with <italic toggle="yes">Blbp-Cre, Ctnnb1<sup>lox(ex3)/lox(ex3)</sup></italic> and <italic toggle="yes">Tp53</italic><sup>flx/flx</sup> mice to generate progeny of the appropriate genotype and subjected to clinical surveillance.</p>
      </sec>
      <sec sec-type="supplementary-material" id="SM">
        <title>Supplementary Material</title>
        <supplementary-material content-type="local-data" id="SD1" position="float" orientation="portrait">
          <label>info</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-info.pdf" mimetype="application" mime-subtype="pdf" orientation="portrait" id="d37e1764" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD10" position="float" orientation="portrait">
          <label>table 2</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_2.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1768" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD11" position="float" orientation="portrait">
          <label>table 3</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_3.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1772" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD12" position="float" orientation="portrait">
          <label>table 4</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_4.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1776" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD13" position="float" orientation="portrait">
          <label>table 5</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_5.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1780" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD14" position="float" orientation="portrait">
          <label>table 6</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_6.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1784" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD15" position="float" orientation="portrait">
          <label>table 7</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_7.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1788" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD16" position="float" orientation="portrait">
          <label>table 8</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_8.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1792" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD17" position="float" orientation="portrait">
          <label>table 9</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_9.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1796" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD2" position="float" orientation="portrait">
          <label>methods</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-methods.doc" mimetype="application" mime-subtype="msword" orientation="portrait" id="d37e1800" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD3" position="float" orientation="portrait">
          <label>table 1</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_1.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1805" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD4" position="float" orientation="portrait">
          <label>table 10</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_10.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1809" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD5" position="float" orientation="portrait">
          <label>table 11</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_11.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1813" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD6" position="float" orientation="portrait">
          <label>table 12</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_12.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1817" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD7" position="float" orientation="portrait">
          <label>table 13</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_13.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1821" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD8" position="float" orientation="portrait">
          <label>table 14</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_14.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1825" position="anchor"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="SD9" position="float" orientation="portrait">
          <label>table 15</label>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS374717-supplement-table_15.xlsx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" id="d37e1829" position="anchor"/>
        </supplementary-material>
      </sec>
    </body>
    <back>
      <ack id="S10">
        <title>Acknowledgements</title>
        <p>This research was supported as part of the St. Jude Children’s Research Hospital, Washington University Pediatric Cancer Genome Project. This work was supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765, R.J.G), the Collaborative Ependymoma Research Network (CERN), Musicians against Childhood Cancer (MACC), The Noyes Brain Tumour Foundation, and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to Sally Temple for the generous gift of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology and ARC at St Jude Children’s Research Hospital for technical assistance.</p>
      </ack>
      <fn-group>
        <fn id="FN2">
          <p id="P26"><bold>Author contributions.</bold> G.R., M.P., T.A.K, C.L., X.C., L.D., T.N.P., E.H., W.L., X.Z., N.C., R.H., N.C., R.T., J.W., G.W., M.R., X.H., J.B., P.G., J.M., J.E., B.V., S.P., D.Z., D.K., D.F., contributed to the design and conduct of experiments and to the writing S.J.B., R.K., M.F.R., R.S.F., L.L.F., D.J.D., K.O., E.R.M., contributed to experimental design and to the writing A.G., D.W.E., C.C.L., E.B., T.H., S.G., R.C., provided clinical expertise. R.K.W., J.R.D., J.Z., and R.J.G., conceived the research and contributed to the design, direction and reporting of the study. No competing financial interests.</p>
        </fn>
        <fn id="FN3">
          <p id="P27"><bold>Competing interests.</bold> None.</p>
        </fn>
        <fn id="FN4">
          <p id="P28"><bold>Supplementary Information.</bold> Supplementary Information is available online.</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="R1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <collab>CBTRUS</collab>
            </person-group>
            <source>Statistical Report: Primary Brain Tumors in the United States, 1995-1999</source>
            <year>2006</year>
            <publisher-name>Central Brain Tumor Registry of the United States</publisher-name>
            <publisher-loc>Hinsdale, IL</publisher-loc>
            <comment>2002</comment>
          </element-citation>
        </ref>
        <ref id="R2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Taylor</surname>
                <given-names>MD</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Molecular subgroups of medulloblastoma: the current consensus</article-title>
            <source>Acta Neuropathol</source>
            <year>2012</year>
            <volume>123</volume>
            <fpage>465</fpage>
            <lpage>472</lpage>
            <comment>Epub 2011 Dec 2012</comment>
            <pub-id pub-id-type="pmid">22134537</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00401-011-0922-z</pub-id>
            <pub-id pub-id-type="pmcid">PMC3306779</pub-id>
          </element-citation>
        </ref>
        <ref id="R3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schuller</surname>
                <given-names>U</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma</article-title>
            <source>Cancer Cell</source>
            <year>2008</year>
            <volume>14</volume>
            <fpage>123</fpage>
            <lpage>134</lpage>
            <pub-id pub-id-type="pmid">18691547</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccr.2008.07.005</pub-id>
            <pub-id pub-id-type="pmcid">PMC2597270</pub-id>
          </element-citation>
        </ref>
        <ref id="R4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>ZJ</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells</article-title>
            <source>Cancer Cell</source>
            <year>2008</year>
            <volume>14</volume>
            <fpage>135</fpage>
            <lpage>145</lpage>
            <pub-id pub-id-type="pmid">18691548</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccr.2008.07.003</pub-id>
            <pub-id pub-id-type="pmcid">PMC2538687</pub-id>
          </element-citation>
        </ref>
        <ref id="R5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gibson</surname>
                <given-names>P</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Subtypes of medulloblastoma have distinct developmental origins</article-title>
            <source>Nature</source>
            <year>2010</year>
            <volume>468</volume>
            <fpage>1095</fpage>
            <lpage>1099</lpage>
            <pub-id pub-id-type="pmid">21150899</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature09587</pub-id>
            <pub-id pub-id-type="pmcid">PMC3059767</pub-id>
          </element-citation>
        </ref>
        <ref id="R6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kawauchi</surname>
                <given-names>D</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>A mouse model of the most aggressive subgroup of human medulloblastoma</article-title>
            <source>Cancer Cell</source>
            <year>2012</year>
            <volume>21</volume>
            <fpage>168</fpage>
            <lpage>180</lpage>
            <pub-id pub-id-type="pmid">22340591</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccr.2011.12.023</pub-id>
            <pub-id pub-id-type="pmcid">PMC3285412</pub-id>
          </element-citation>
        </ref>
        <ref id="R7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mulhern</surname>
                <given-names>RK</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Neurocognitive Consequences of Risk-Adapted Therapy for Childhood Medulloblastoma</article-title>
            <source>Journal of Clinical Oncology</source>
            <year>2005</year>
            <volume>23</volume>
            <fpage>5511</fpage>
            <lpage>5519</lpage>
            <pub-id pub-id-type="pmid">16110011</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2005.00.703</pub-id>
          </element-citation>
        </ref>
        <ref id="R8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>CREST maps somatic structural variation in cancer genomes with base-pair resolution</article-title>
            <source>Nat Meth</source>
            <year>2011</year>
            <volume>8</volume>
            <fpage>652</fpage>
            <lpage>654</lpage>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.1628</pub-id>
            <pub-id pub-id-type="pmcid">PMC3527068</pub-id>
            <pub-id pub-id-type="pmid">21666668</pub-id>
          </element-citation>
        </ref>
        <ref id="R9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rausch</surname>
                <given-names>T</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations</article-title>
            <source>Cell</source>
            <year>2012</year>
            <volume>148</volume>
            <fpage>59</fpage>
            <lpage>71</lpage>
            <comment>doi:10.1016/j.cell.2011.12.013</comment>
            <pub-id pub-id-type="pmid">22265402</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2011.12.013</pub-id>
            <pub-id pub-id-type="pmcid">PMC3332216</pub-id>
          </element-citation>
        </ref>
        <ref id="R10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Castellino</surname>
                <given-names>RC</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma</article-title>
            <source>PLoS One</source>
            <year>2010</year>
            <volume>5</volume>
            <fpage>e10849</fpage>
            <pub-id pub-id-type="pmid">20520772</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0010849</pub-id>
            <pub-id pub-id-type="pmcid">PMC2877103</pub-id>
          </element-citation>
        </ref>
        <ref id="R11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hahn</surname>
                <given-names>H</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome</article-title>
            <source>Cell</source>
            <year>1996</year>
            <volume>85</volume>
            <fpage>841</fpage>
            <lpage>851</lpage>
            <pub-id pub-id-type="pmid">8681379</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(00)81268-4</pub-id>
          </element-citation>
        </ref>
        <ref id="R12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Malkin</surname>
                <given-names>D</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms</article-title>
            <source>Science</source>
            <year>1990</year>
            <volume>250</volume>
            <fpage>1233</fpage>
            <lpage>1238</lpage>
            <pub-id pub-id-type="pmid">1978757</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1978757</pub-id>
          </element-citation>
        </ref>
        <ref id="R13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hamilton</surname>
                <given-names>SR</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The molecular basis of Turcot’s syndrome</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <volume>332</volume>
            <fpage>839</fpage>
            <lpage>847</lpage>
            <pub-id pub-id-type="pmid">7661930</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199503303321302</pub-id>
          </element-citation>
        </ref>
        <ref id="R14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Taylor</surname>
                <given-names>MD</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Medulloblastoma in a child with Rubenstein-Taybi Syndrome: case report and review of the literature</article-title>
            <source>Pediatr Neurosurg</source>
            <year>2001</year>
            <volume>35</volume>
            <fpage>235</fpage>
            <lpage>238</lpage>
            <pub-id pub-id-type="pmid">11741116</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000050428</pub-id>
          </element-citation>
        </ref>
        <ref id="R15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mikkelsen</surname>
                <given-names>TS</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells</article-title>
            <source>Nature</source>
            <year>2007</year>
            <volume>448</volume>
            <fpage>553</fpage>
            <lpage>560</lpage>
            <pub-id pub-id-type="pmid">17603471</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature06008</pub-id>
            <pub-id pub-id-type="pmcid">PMC2921165</pub-id>
          </element-citation>
        </ref>
        <ref id="R16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cao</surname>
                <given-names>R</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Role of histone H3 lysine 27 methylation in Polycomb-group silencing</article-title>
            <source>Science</source>
            <year>2002</year>
            <volume>298</volume>
            <fpage>1039</fpage>
            <lpage>1043</lpage>
            <comment>Epub 2002 Sep 1026</comment>
            <pub-id pub-id-type="pmid">12351676</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1076997</pub-id>
          </element-citation>
        </ref>
        <ref id="R17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Czermin</surname>
                <given-names>B</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites</article-title>
            <source>Cell</source>
            <year>2002</year>
            <volume>111</volume>
            <fpage>185</fpage>
            <lpage>196</lpage>
            <pub-id pub-id-type="pmid">12408863</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(02)00975-3</pub-id>
          </element-citation>
        </ref>
        <ref id="R18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Agger</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development</article-title>
            <source>Nature</source>
            <year>2007</year>
            <volume>449</volume>
            <fpage>731</fpage>
            <lpage>734</lpage>
            <pub-id pub-id-type="pmid">17713478</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature06145</pub-id>
          </element-citation>
        </ref>
        <ref id="R19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schnetz</surname>
                <given-names>MP</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns</article-title>
            <source>Genome Research</source>
            <year>2009</year>
            <volume>19</volume>
            <fpage>590</fpage>
            <lpage>601</lpage>
            <pub-id pub-id-type="pmid">19251738</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gr.086983.108</pub-id>
            <pub-id pub-id-type="pmcid">PMC2665778</pub-id>
          </element-citation>
        </ref>
        <ref id="R20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sauvageau</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Sauvageau</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer</article-title>
            <source>Cell Stem Cell</source>
            <year>2010</year>
            <volume>7</volume>
            <fpage>299</fpage>
            <lpage>313</lpage>
            <pub-id pub-id-type="pmid">20804967</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stem.2010.08.002</pub-id>
            <pub-id pub-id-type="pmcid">PMC4959883</pub-id>
          </element-citation>
        </ref>
        <ref id="R21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Morin</surname>
                <given-names>RD</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin</article-title>
            <source>Nat Genet</source>
            <year>2010</year>
            <volume>42</volume>
            <fpage>181</fpage>
            <lpage>185</lpage>
            <pub-id pub-id-type="pmid">20081860</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.518</pub-id>
            <pub-id pub-id-type="pmcid">PMC2850970</pub-id>
          </element-citation>
        </ref>
        <ref id="R22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kleer</surname>
                <given-names>CG</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</article-title>
            <source>Proceedings of the National Academy of Sciences</source>
            <year>2003</year>
            <volume>100</volume>
            <fpage>11606</fpage>
            <lpage>11611</lpage>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1933744100</pub-id>
            <pub-id pub-id-type="pmcid">PMC208805</pub-id>
            <pub-id pub-id-type="pmid">14500907</pub-id>
          </element-citation>
        </ref>
        <ref id="R23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Varambally</surname>
                <given-names>S</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The polycomb group protein EZH2 is involved in progression of prostate cancer</article-title>
            <source>Nature</source>
            <year>2002</year>
            <volume>419</volume>
            <fpage>624</fpage>
            <lpage>629</lpage>
            <pub-id pub-id-type="pmid">12374981</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature01075</pub-id>
          </element-citation>
        </ref>
        <ref id="R24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>van Haaften</surname>
                <given-names>G</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer</article-title>
            <source>Nat Genet</source>
            <year>2009</year>
            <volume>41</volume>
            <fpage>521</fpage>
            <lpage>523</lpage>
            <pub-id pub-id-type="pmid">19330029</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.349</pub-id>
            <pub-id pub-id-type="pmcid">PMC2873835</pub-id>
          </element-citation>
        </ref>
        <ref id="R25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Babak</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Shendure</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Disteche</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Global survey of escape from X inactivation by RNA-sequencing in mouse</article-title>
            <source>Genome Research</source>
            <year>2010</year>
            <volume>20</volume>
            <fpage>614</fpage>
            <lpage>622</lpage>
            <pub-id pub-id-type="pmid">20363980</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gr.103200.109</pub-id>
            <pub-id pub-id-type="pmcid">PMC2860163</pub-id>
          </element-citation>
        </ref>
        <ref id="R26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Christensen</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3</article-title>
            <source>Cell</source>
            <year>2007</year>
            <volume>128</volume>
            <fpage>1063</fpage>
            <lpage>1076</lpage>
            <pub-id pub-id-type="pmid">17320161</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2007.02.003</pub-id>
          </element-citation>
        </ref>
        <ref id="R27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lee</surname>
                <given-names>MG</given-names>
              </name>
              <name name-style="western">
                <surname>Wynder</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Cooch</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Shiekhattar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation</article-title>
            <source>Nature</source>
            <year>2005</year>
            <volume>437</volume>
            <fpage>432</fpage>
            <lpage>435</lpage>
            <pub-id pub-id-type="pmid">16079794</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature04021</pub-id>
          </element-citation>
        </ref>
        <ref id="R28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mosimann</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Hausmann</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Basler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[beta]-Catenin hits chromatin: regulation of Wnt target gene activation</article-title>
            <source>Nat Rev Mol Cell Biol</source>
            <year>2009</year>
            <volume>10</volume>
            <fpage>276</fpage>
            <lpage>286</lpage>
            <pub-id pub-id-type="pmid">19305417</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm2654</pub-id>
          </element-citation>
        </ref>
        <ref id="R29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hecht</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Vleminckx</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Stemmler</surname>
                <given-names>MP</given-names>
              </name>
              <name name-style="western">
                <surname>van Roy</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Kemler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The p300/CBP acetyltransferases function as transcriptional coactivators of [beta]-catenin in vertebrates</article-title>
            <source>EMBO J</source>
            <year>2000</year>
            <volume>19</volume>
            <fpage>1839</fpage>
            <lpage>1850</lpage>
            <pub-id pub-id-type="pmid">10775268</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/19.8.1839</pub-id>
            <pub-id pub-id-type="pmcid">PMC302022</pub-id>
          </element-citation>
        </ref>
        <ref id="R30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Barker</surname>
                <given-names>N</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The chromatin remodelling factor Brg-1 interacts with [beta]-catenin to promote target gene activation</article-title>
            <source>EMBO J</source>
            <year>2001</year>
            <volume>20</volume>
            <fpage>4935</fpage>
            <lpage>4943</lpage>
            <pub-id pub-id-type="pmid">11532957</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/20.17.4935</pub-id>
            <pub-id pub-id-type="pmcid">PMC125268</pub-id>
          </element-citation>
        </ref>
        <ref id="R31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Carrera</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Janody</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Leeds</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Duveau</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Treisman</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13</article-title>
            <source>Proceedings of the National Academy of Sciences</source>
            <year>2008</year>
            <volume>105</volume>
            <fpage>6644</fpage>
            <lpage>6649</lpage>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0709749105</pub-id>
            <pub-id pub-id-type="pmcid">PMC2373359</pub-id>
            <pub-id pub-id-type="pmid">18451032</pub-id>
          </element-citation>
        </ref>
        <ref id="R32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Thompson</surname>
                <given-names>MC</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations</article-title>
            <source>J Clin Oncol</source>
            <year>2006</year>
            <volume>24</volume>
            <fpage>1924</fpage>
            <lpage>1931</lpage>
            <comment>Epub 2006 Mar 1927</comment>
            <pub-id pub-id-type="pmid">16567768</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2005.04.4974</pub-id>
          </element-citation>
        </ref>
        <ref id="R33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kool</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features</article-title>
            <source>PLoS One</source>
            <year>2008</year>
            <volume>3</volume>
            <fpage>e3088</fpage>
            <pub-id pub-id-type="pmid">18769486</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0003088</pub-id>
            <pub-id pub-id-type="pmcid">PMC2518524</pub-id>
          </element-citation>
        </ref>
        <ref id="R34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Orsulic</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Huber</surname>
                <given-names>O</given-names>
              </name>
              <name name-style="western">
                <surname>Aberle</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Arnold</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Kemler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation</article-title>
            <source>Journal of Cell Science</source>
            <year>1999</year>
            <volume>112</volume>
            <fpage>1237</fpage>
            <lpage>1245</lpage>
            <pub-id pub-id-type="pmid">10085258</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/jcs.112.8.1237</pub-id>
          </element-citation>
        </ref>
        <ref id="R35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Risinger</surname>
                <given-names>JI</given-names>
              </name>
              <name name-style="western">
                <surname>Berchuck</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Kohler</surname>
                <given-names>MF</given-names>
              </name>
              <name name-style="western">
                <surname>Boyd</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mutations of the E-cadherin gene in human gynecologic cancers</article-title>
            <source>Nat Genet</source>
            <year>1994</year>
            <volume>7</volume>
            <fpage>98</fpage>
            <lpage>102</lpage>
            <pub-id pub-id-type="pmid">8075649</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng0594-98</pub-id>
          </element-citation>
        </ref>
        <ref id="R36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Becker</surname>
                <given-names>K-F</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>E-Cadherin Gene Mutations Provide Clues to Diffuse Type Gastric Carcinomas</article-title>
            <source>Cancer Research</source>
            <year>1994</year>
            <volume>54</volume>
            <fpage>3845</fpage>
            <lpage>3852</lpage>
            <pub-id pub-id-type="pmid">8033105</pub-id>
          </element-citation>
        </ref>
        <ref id="R37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pek</surname>
                <given-names>JW</given-names>
              </name>
              <name name-style="western">
                <surname>Kai</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregation</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2011</year>
            <volume>108</volume>
            <fpage>12007</fpage>
            <lpage>12012</lpage>
            <pub-id pub-id-type="pmid">21730191</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1106245108</pub-id>
            <pub-id pub-id-type="pmcid">PMC3141994</pub-id>
          </element-citation>
        </ref>
        <ref id="R38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lai</surname>
                <given-names>MC</given-names>
              </name>
              <name name-style="western">
                <surname>Chang</surname>
                <given-names>WC</given-names>
              </name>
              <name name-style="western">
                <surname>Shieh</surname>
                <given-names>SY</given-names>
              </name>
              <name name-style="western">
                <surname>Tarn</surname>
                <given-names>WY</given-names>
              </name>
            </person-group>
            <article-title>DDX3 regulates cell growth through translational control of cyclin E1</article-title>
            <source>Mol Cell Biol</source>
            <year>2010</year>
            <volume>30</volume>
            <fpage>5444</fpage>
            <lpage>5453</lpage>
            <pub-id pub-id-type="pmid">20837705</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.00560-10</pub-id>
            <pub-id pub-id-type="pmcid">PMC2976371</pub-id>
          </element-citation>
        </ref>
        <ref id="R39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schroder</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation</article-title>
            <source>Biochem Pharmacol</source>
            <year>2010</year>
            <volume>79</volume>
            <fpage>297</fpage>
            <lpage>306</lpage>
            <pub-id pub-id-type="pmid">19782656</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2009.08.032</pub-id>
          </element-citation>
        </ref>
        <ref id="R40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Samuels</surname>
                <given-names>Y</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>High frequency of mutations of the PIK3CA gene in human cancers</article-title>
            <source>Science</source>
            <year>2004</year>
            <volume>304</volume>
            <fpage>554</fpage>
            <pub-id pub-id-type="pmid">15016963</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1096502</pub-id>
          </element-citation>
        </ref>
        <ref id="R41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Broderick</surname>
                <given-names>DK</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas</article-title>
            <source>Cancer Res</source>
            <year>2004</year>
            <volume>64</volume>
            <fpage>5048</fpage>
            <lpage>5050</lpage>
            <pub-id pub-id-type="pmid">15289301</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-04-1170</pub-id>
          </element-citation>
        </ref>
        <ref id="R42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Parsons</surname>
                <given-names>DW</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The genetic landscape of the childhood cancer medulloblastoma</article-title>
            <source>Science</source>
            <year>2011</year>
            <volume>331</volume>
            <fpage>435</fpage>
            <lpage>439</lpage>
            <pub-id pub-id-type="pmid">21163964</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1198056</pub-id>
            <pub-id pub-id-type="pmcid">PMC3110744</pub-id>
          </element-citation>
        </ref>
        <ref id="R43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Andang</surname>
                <given-names>M</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation</article-title>
            <source>Nature</source>
            <year>2008</year>
            <volume>451</volume>
            <fpage>460</fpage>
            <lpage>464</lpage>
            <pub-id pub-id-type="pmid">18185516</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature06488</pub-id>
          </element-citation>
        </ref>
        <ref id="R44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pasini</surname>
                <given-names>D</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2</article-title>
            <source>Genes &amp; Development</source>
            <year>2008</year>
            <volume>22</volume>
            <fpage>1345</fpage>
            <lpage>1355</lpage>
            <pub-id pub-id-type="pmid">18483221</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.470008</pub-id>
            <pub-id pub-id-type="pmcid">PMC2377189</pub-id>
          </element-citation>
        </ref>
        <ref id="R45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Shover</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Goodliffe</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Su(z)2 Antagonizes Auto-Repression of Myc in Drosophila, Increasing Myc Levels and Subsequent Trans-Activation</article-title>
            <source>PLoS One</source>
            <year>2009</year>
            <volume>4</volume>
            <fpage>e5076</fpage>
            <pub-id pub-id-type="pmid">19333393</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0005076</pub-id>
            <pub-id pub-id-type="pmcid">PMC2659448</pub-id>
          </element-citation>
        </ref>
        <ref id="R46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Northcott</surname>
                <given-names>PA</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Medulloblastoma comprises four distinct molecular variants</article-title>
            <source>J Clin Oncol</source>
            <year>2011</year>
            <volume>29</volume>
            <fpage>1408</fpage>
            <lpage>1414</lpage>
            <comment>Epub 2010 Sep 1407</comment>
            <pub-id pub-id-type="pmid">20823417</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2009.27.4324</pub-id>
            <pub-id pub-id-type="pmcid">PMC4874239</pub-id>
          </element-citation>
        </ref>
        <ref id="R47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Spatz</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Borg</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Feunteun</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>X-Chromosome Genetics and Human Cancer</article-title>
            <source>Nat Rev Cancer</source>
            <year>2004</year>
            <volume>4</volume>
            <fpage>617</fpage>
            <lpage>629</lpage>
            <pub-id pub-id-type="pmid">15286741</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc1413</pub-id>
          </element-citation>
        </ref>
        <ref id="R48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lindqvist</surname>
                <given-names>L</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Selective Pharmacological Targeting of a DEAD Box RNA Helicase</article-title>
            <source>PLoS One</source>
            <year>2008</year>
            <volume>3</volume>
            <fpage>e1583</fpage>
            <pub-id pub-id-type="pmid">18270573</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0001583</pub-id>
            <pub-id pub-id-type="pmcid">PMC2216682</pub-id>
          </element-citation>
        </ref>
        <ref id="R49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Engelman</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Targeting PI3K signalling in cancer: opportunities, challenges and limitations</article-title>
            <source>Nat Rev Cancer</source>
            <year>2009</year>
            <volume>9</volume>
            <fpage>550</fpage>
            <lpage>562</lpage>
            <pub-id pub-id-type="pmid">19629070</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc2664</pub-id>
          </element-citation>
        </ref>
        <ref id="R50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>The genetic basis of early T-cell precursor acute lymphoblastic leukaemia</article-title>
            <source>Nature</source>
            <year>2012</year>
            <volume>481</volume>
            <fpage>157</fpage>
            <lpage>163</lpage>
            <pub-id pub-id-type="pmid">22237106</pub-id>
            <pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature10725</pub-id>
            <pub-id pub-id-type="pmcid">PMC3267575</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
    <floats-group>
      <fig id="F1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <title>The genomic landscape of medulloblastoma</title>
          <p>Top: clinical, histologic, gross chromosomal, nuclear CTNNB1 (nCTNNB1), and cohort (discovery or validation) details of 79 medulloblastomas by subgroup. Below: genetic alterations detected in 27 genes of particular interest. Color key at bottom. ANOVA (continuous) or Fisher’s exact (categorical) p-value is shown right. False discovery estimates (FDR) of each mutation are shown right. ***=P&lt;0.0005; **=P&lt;0.005; *=P&lt;0.05; ns=not significant.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-374717-f0001.jpg"/>
      </fig>
      <fig id="F2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <title>Deregulation of H3K27me3 in subgroup-3 and 4 human and mouse medulloblastoma</title>
          <p><bold>(a)</bold> Top row, SNP profiles of chromosome 7 copy number in medulloblastomas (samples as <xref ref-type="fig" rid="F1">Figure 1</xref>; *=subgroup-3 cases). Second row, expression of EZH2. Subgroup-3 and 4 tumours are ordered left to right by expression level, #=median expression point (Bonferroni corrected p-value of EZH2 expression vs. chromosome 7 gain). Third row, mutation status of <italic toggle="yes">KDM6A, CHD7</italic> and <italic toggle="yes">ZMYM3</italic> (p-value, Fisher’s exact mutations vs. EZH2 expression). Fourth row, H3K27me3 immunohistochemistry (numbers=colorimetry, p-value ANOVA). <bold>(b)</bold> H3K27me3 expression (right) in mouse <italic toggle="yes">Blbp-Cre</italic> ; <italic toggle="yes">Ctnnb1<sup>+/lox(Ex3)</sup></italic> ; <italic toggle="yes">Tp53<sup>flx/flx</sup></italic> (WNT), <italic toggle="yes">Ptch1<sup>+/−</sup></italic>; <italic toggle="yes">Tp53<sup>−/−</sup></italic> (SHH) and <italic toggle="yes">Myc</italic> ; Ink4c<sup>−/−</sup> (group 3) medulloblastomas and (left) developing hindbrain. high power views of E14.5 (i) LRL and (ii) upper rhombic lip (URL). IGL=internal granule layer, EGL=external germinal layer. Scale bar=50μm. White arrows in P7 cerebellum pinpoint H3K27me3 cells in the EGL.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-374717-f0002.jpg"/>
      </fig>
      <fig id="F3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <title>Genes mutated in WNT-subgroup medulloblastomas regulate LRLPs</title>
          <p><bold>(a)</bold> Isolated Olig3<sup>+</sup><bold>/</bold>Wnt1<sup>+</sup> LRLPs were transduced in <bold>(b)</bold> with mutant Ctnnb1 (above hashed line) or the indicated shRNA-Red Fluorescence Protein construct (below hashed line). LRLPs were also transduced (+) or not (−) with a Tcf-Lef-enhanced green fluorescence (Tcf) reporter. Numbers right report clonal % 2′ to 3′ passage neurosphere formation (+SD). <bold>(c)</bold> Knock-down of genes targeted by shRNA relative to control transduced cells. <bold>(d)</bold> Immunofluorescence of P1 mouse hindbrains electroporated <italic toggle="yes">in utero</italic> at E14.5 with GFP (to control for equivalence of electroporation between embryos control) and the indicated construct. High-power views of indicated areas are shown right. Cells targeted by Ddx3x-shRNA are present 48 hours post electroporation but ablated by P1. Scale=200μm. <bold>(e)</bold> Heatmap reporting the distribution of GFP<sup>+</sup>/RFP<sup>+</sup> cells in eletroporated mice at P1. Median distance migrated by cells, and p-values of migration distance and cell number relative to controls is shown (****, p&lt;0.00005; ***, p&lt;0.0005; **, p&lt;0.005; *, p&lt;0.05. Red and green text reports significant increase or decrease, respectively relative to control).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-374717-f0003.jpg"/>
      </fig>
      <fig id="F4" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <title><italic toggle="yes">Pik3ca<sup>E545K</sup></italic> accelerates but does not initiate WNT-subgroup medulloblastoma</title>
          <p>Tumour free survival of mice of the indicated genotype. All mice carry the <italic toggle="yes">Blbp-cre</italic> allele. Log Rank P&lt;0.0001. <bold>(b)</bold> Hematoxylin and eosin and immunohistochemical stains of indicated tumors. Scale=50 μm.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-374717-f0004.jpg"/>
      </fig>
    </floats-group>
  </article>
</pmc-articleset>
